Linfang Deng

Ms. Linfang Deng


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2024 in International Journal of Surgery
Verified
Journal Article
Open access
LDLinfang Deng
Linfang Deng
TWTianyi Wang
Tianyi Wang
YAYangzhang
Yangzhang
ZZZhenhua Zhai
Zhenhua Zhai
WTWei Tao
Wei Tao
JXJinjiang Xu
Jinjiang Xu
Background: Large language models (LLMs) have garnered significant attention in the AI domain owing to their exemplary context recognition and response capabilities. However, the potential of LLMs in specific clinical scenarios, particularly in breast cancer diagnosis, treatment, and care, has not been fully explored. This study aimed to compare the performances of three major LLMs in the clinical context of breast cancer. Methods: In this study, clinical scenarios designed specifically for breast cancer were segmented into five pivotal domains (nine cases): assessment and diagnosis, treatment decision-making, postoperative care, psychosocial support, and prognosis and rehabilitation. The LLMs were used to generate feedback for various queries related to these domains. For each scenario, a panel of five breast cancer specialists, each with over a decade of experience, evaluated the feedback from LLMs. They assessed feedback concerning LLMs in terms of their quality, relevance, and applicability. Results: There was a moderate level of agreement among the raters (Fleiss’ kappa=0.345, P<0.05). Comparing the performance of different models regarding response length, GPT-4.0 and GPT-3.5 provided relatively longer feedback than Claude2. Furthermore, across the nine case analyses, GPT-4.0 significantly outperformed the other two models in average quality, relevance, and applicability. Within the five clinical areas, GPT-4.0 markedly surpassed GPT-3.5 in the quality of the other four areas and scored higher than Claude2 in tasks related to psychosocial support and treatment decision-making. Conclusion: This study revealed that in the realm of clinical applications for breast cancer, GPT-4.0 showcases not only superiority in terms of quality and relevance but also demonstrates exceptional capability in applicability, especially when compared to GPT-3.5. Relative to Claude2, GPT-4.0 holds advantages in specific domains. With the expanding use of LLMs in the clinical field, ongoing optimization and rigorous accuracy assessments are paramount.

21 September 2023 in International Journal of Surgery
Verified
Journal Article
Open access
SLShaoting Luo
Shaoting Luo
LDLinfang Deng
Linfang Deng
YCYufan Chen
Yufan Chen
WZWeizheng Zhou
Weizheng Zhou
Federico CanaveseFederico Canavese
Federico Canavese
LLLian-Yong LI
Lian-Yong LI
An abstract is unavailable. This article is available as a PDF only.

5 September 2023 in International Journal of Surgery
Verified
Journal Article
Open access
LDLinfang Deng
Linfang Deng
YZYang Zhang
Yang Zhang
SLShaoting Luo
Shaoting Luo
JXJinjiang Xu
Jinjiang Xu
An abstract is unavailable. This article is available as a PDF only.

28 November 2025 in BMC Women's Health
Verified
Journal Article
Open access
PDF file
QFQianna Fang
Qianna Fang
HJHongmei Jiang
Hongmei Jiang
LDLinfang Deng
Linfang Deng
WSWeiming Sun
Weiming Sun
MWMei Wang
Mei Wang
JXJinjiang Xu
Jinjiang Xu
The aim of this study was to construct and internally validate a prediction model for the risk of preoperative frailty in Chinese breast cancer patients. F